A cancer drug slowed brain tumor cells in lab dishes
Original title: Anlotinib inhibits glioma cell proliferation, migration, and invasion by suppressing c-MET/AKT/mTOR signaling and altering autophagy-associated protein expression.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in a dish, not in people.
The short version
In a lab, a drug called anlotinib slowed down brain tumor cells growing in dishes.
What was studied. Researchers tested a drug called anlotinib on two kinds of human glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary cells, U87 and U251. The cells were grown in dishes, not in people or animals.
What they found. Anlotinib lowered the number of living tumor cells. The more drug they used, the fewer cells stayed alive. At lower amounts, the drug also slowed the cells from moving and spreading across the dish. The team saw changes in proteins tied to cell death, cell movement, and the way cells clean out their own parts.
What this means, and what it doesn't
What it could mean: This is an early lab clue, not a treatment. It points researchers toward one path this drug may act on in glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary cells. Work like this can help scientists decide what to test next.
What it doesn't mean: This does not mean anlotinib treats brain tumors. The work was done only on cells in a dish. It was not tested in people, and it was not tested in animals here. Cells in a dish often act differently than a tumor in a person. This is not a cure, and it is not something a doctor can offer you today. Many lab findings never become treatments.
Source: PubMed, September 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.